{"id":"W4404567325","doi":"10.1136/jitc-2024-010143","title":"Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1)","year":2024,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Alberta Health Services; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; CD8; Cytokine; Oncology; Response Evaluation Criteria in Solid Tumors; Melanoma; Aldesleukin; Adverse effect; Cancer; Interleukin 2; Gastroenterology; Immunotherapy; Immunology; Phases of clinical research; Toxicity; Cancer research; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002567486,0.0003770844,0.000717001,0.0003951941,0.000104565,0.0001079599,0.0001650729,0.0001131035,0.0001930205],"category_scores_gemma":[0.000008424989,0.0002511771,0.0001928141,0.0004013402,0.0002214898,0.0003423923,0.0000111397,0.0004114289,8.111066e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000403613,"about_ca_system_score_gemma":0.0006042251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000286991,"about_ca_topic_score_gemma":0.0001395108,"domain_scores_codex":[0.9979624,0.00003677321,0.0007100372,0.0003819164,0.000469537,0.0004393814],"domain_scores_gemma":[0.9989746,0.00007457905,0.0003135358,0.0002798359,0.0002415871,0.0001158341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3038473,0.0006473728,0.03368223,0.0006687028,0.002925839,0.0001138298,0.003117482,0.0004280373,0.06396857,0.0001529452,0.0007108245,0.5897369],"study_design_scores_gemma":[0.217357,0.047501,0.5198852,0.01926282,0.0006470273,0.001532652,0.001139161,0.001990064,0.06763128,0.001181351,0.1195431,0.002329272],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784475,0.0183782,0.0006067713,0.000848886,0.000337177,0.001066616,0.00006761942,0.00004000096,0.0002072507],"genre_scores_gemma":[0.9912219,0.005862959,0.0008739083,0.0006515873,0.0001490337,0.0001718052,0.00001516787,0.0001272313,0.0009263943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5874076,"threshold_uncertainty_score":0.999994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007401104382701864,"score_gpt":0.3007189979122338,"score_spread":0.293317893529532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}